Concert
is a Massachusetts-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of autoimmune diseases... Read moreConcert
is a Massachusetts-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of autoimmune diseases... Read more
News
Mar 20, 2023
Medthority
Concert: Phase III THRIVE-AA2 trial of CTP 543 in alopecia areata presented at the American Academy of Dermatology's (AAD) 2023 Annual Meeting.- Concert Pharma
Mar 20, 2023
Indian Pharma Post
Concert: Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
Mar 07, 2023
Indian Pharma Post
Concert: Sun Pharma completes acquisition of Concert Pharmaceuticals
Feb 16, 2023
Seeking Alpha
Concert: Concert Pharmaceuticals: Negative Spread But Interesting CVR
Feb 15, 2023
Business Wire
Press Release: Concert : Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata
Jan 26, 2023
Global Legal Chronicle
Concert: Sun Pharmaceutical's $576 Million Acquisition of Concert Pharmaceuticals
Jan 24, 2023
Outsourcing-Pharma
Concert: Sun Pharma spends $576m to get hands on hair loss drug
Jan 24, 2023
LaingBuisson
Concert: India: Sun Pharma to acquire Concert Pharmaceuticals shares for US$576m
Jan 21, 2023
Medthority
Concert: Concert Pharma is acquuired by Sun Pharma and with it deuruxolitinib a proposed treatment for Alopecia Areata.
Jan 20, 2023
Fii News
Concert: Markets: Sun Pharma makes $576m offer to takeover Concert of Lexington
Concert Competitors
1
2
3
4
5
6
7
8
9
10